Retrospective analyses incorporating CXCR4-directed ERT in chemotherapy-based conditioning before auto- or alloSCT in hematologic malignancies such as T- and B-cell lymphomas, multiple myeloma and leukemia have confirmed adequate engraftment 33, 38-40. The gene discussed is CXCR4; the disease is plasma cell myeloma.